ALS

Vanderbilt NeuroCline, a consortium of researchers from Vanderbilt Health and Vanderbilt University, has received a prestigious award to explore using artificial intelligence to find new drug targets for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease. Read More

A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently. Read More

The process, discovered in the axons of neurons, is implicated in Alzheimer’s, amyotrophic lateral sclerosis, traumatic brain injury and other diseases or injuries to the nervous system. Read More

Members of Vanderbilt’s ALS clinic stepped up and took the ice bucket challenge Wednesday to raise awareness for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Read More